Evidence map›Paper›PMID 38506348›Full record

ArticleThe Journal of international medical research2024

Expression and clinical role of

Zixin Chen, Junjun Lin, Huifang Wang, Jing Wang, Zhou Zhang

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Zixin ChenKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Centre of Neuroregeneration, Nantong University, Nantong, Jiangsu Province, China.
Junjun LinDepartment of Clinical Laboratory, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Huifang WangDepartment of Clinical Laboratory, Affiliated Huishan Hospital of Xinglin College, Nantong University, Wuxi Huishan District People's Hospital, Wuxi, Jiangsu Province, China.
Jing WangDepartment of Clinical Laboratory, Affiliated Huishan Hospital of Xinglin College, Nantong University, Wuxi Huishan District People's Hospital, Wuxi, Jiangsu Province, China.
Zhou ZhangDepartment of Clinical Laboratory, Affiliated Huishan Hospital of Xinglin College, Nantong University, Wuxi Huishan District People's Hospital, Wuxi, Jiangsu Province, China.ORCID 0009-0008-7284-3839
Wuxi People's Hospital · CNNantong University · CNSecond Affiliated Hospital of Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the levels of expression and clinical role of peroxiredoxin 6 (

methodsThis retrospective study used a series of bioinformatics methods to detect the levels of expression of and mutations in the

resultsThe results showed that the

conclusion

Indexed as

Adenocarcinoma of LungLung NeoplasmsCell LineHumansPeroxiredoxin VIRetrospective StudiesPeroxiredoxin VIPRDX6 protein, humandiagnostic efficacyexpressionlung adenocarcinomaPRDX6survival analysis

Identifiers

PMID38506348
PMCPMC10956161
OpenAlexW4393003162

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.